SSSW(SH:688399) Xin Lang Cai Jing·2025-11-07 02:14Group 1 - The core viewpoint of the news is that Shuoshi Biotechnology has shown significant stock price performance and trading activity, with a year-to-date increase of 89.73% and a market capitalization of 6.525 billion yuan [1] - As of November 7, the stock price reached 77.80 yuan per share, with a trading volume of 35.4253 million yuan and a turnover rate of 0.55% [1] - The company has experienced net outflows of main funds amounting to 629,500 yuan, while large orders showed a mixed trend with total buy orders of 5.3918 million yuan and sell orders of 6.1871 million yuan [1] Group 2 - Shuoshi Biotechnology, established on April 12, 2010, specializes in the research, production, and sales of in vitro diagnostic products, with a revenue composition of 85.89% from testing reagents [2] - The company is categorized under the pharmaceutical and biological industry, specifically in medical devices and in vitro diagnostics, and is involved in various concept sectors including small-cap stocks and high dividends [2] - For the period from January to September 2025, the company reported a revenue of 258 million yuan, a year-on-year decrease of 3.95%, and a net profit attributable to the parent company of 3.1517 million yuan, down 88.38% year-on-year [2] Group 3 - Since its A-share listing, Shuoshi Biotechnology has distributed a total of 1.37 billion yuan in dividends, with 285 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders decreased by 0.94% to 7,620, while the average circulating shares per person increased by 0.94% to 11,006 shares [2][3]